Growth stimulation of Brevibacterium sp. by siderophores.
OBJECTIVE
To assess which types of siderophores are typically produced by Brevibacterium and how siderophore production and utilization traits are distributed within this genus.


RESULTS
During co-cultivation experiments it was found that growth of B. linens Br5 was stimulated by B. linens NIZO B1410 by two orders of magnitude. The stimulation was caused by the production of hydroxamate siderophores by B. linens NIZO B1410 that enabled the siderophore-auxotrophic strain Br5 to grow faster under the applied iron-limited growth conditions. Different patterns of siderophore production and utilization were observed within the genus Brevibacterium. These patterns did not reflect the phylogenetic relations within the group as determined by partial 16S rDNA sequencing. Most Brevibacterium strains were found to utilize hydroxamate siderophores.


CONCLUSIONS
Brevibacteria can produce and utilize siderophores although certain strains within this genus are siderophore-auxotrophic.


CONCLUSIONS
It is reported for the first time that brevibacteria produce and utilize siderophores. This knowledge can be utilized to stimulate growth of auxotrophic strains under certain conditions. Enhancing the growth rate of Brevibacterium is of importance for the application of this species, for example, for cheese manufacturing or for industrial production of enzymes or metabolites.
Noordman
W H
WH
NIZO Food Research, Ede, the Netherlands. wouter.noordman@campina.com
Reissbrodt
R
R
Bongers
R S
RS
Rademaker
J L W
JL
Bockelmann
W
W
Smit
G
G
D001431:Bacteriological Techniques; D001951:Brevibacterium / Q000254:growth & development* / Q000378:metabolism; D002396:Catechols / Q000378:metabolism; D003470:Culture Media; D004269:DNA, Bacterial / Q000235:genetics; D004275:DNA, Ribosomal / Q000235:genetics; D003676:Deferoxamine / Q000378:metabolism / Q000493:pharmacokinetics; D005029:Ethylenediamines / Q000378:metabolism; D005290:Ferric Compounds / Q000378:metabolism / Q000493:pharmacokinetics; D005291:Ferrichrome / Q000031:analogs & derivatives / Q000378:metabolism / Q000493:pharmacokinetics; D005516:Food Microbiology; D062385:Hydroxybenzoates; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000378:metabolism / Q000493:pharmacokinetics; D010802:Phylogeny; D010879:Piperazines / Q000378:metabolism; D017262:Siderophores / Q000096:biosynthesis / Q000378:metabolism* / Q000493:pharmacokinetics
D002396:Catechols; D003470:Culture Media; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D005029:Ethylenediamines; D005290:Ferric Compounds; D062385:Hydroxybenzoates; D007502:Iron Chelating Agents; D010879:Piperazines; D017262:Siderophores; C011813:ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid); C031058:ferrichrome A; D005291:Ferrichrome; C002577:ferrioxamine B; C003305:rhodotorulic acid; C009135:2,3-dihydroxybenzoic acid; D007501:Iron; D003676:Deferoxamine